Aaron Allen

Moderna Therapeutics
Director, Manufacturing Sciences and Technology
Aaron Allen is an experienced Manufacturing Sciences and Technology professional with more than 25 years of process engineering, manufacturing and MS&T experience in positions of increasing responsibility at Diosynth, Biogen, Jacobs Engineering, Novartis Vaccines and Moderna. Mr. Allen has transferred and executed process validation for multiple vaccines within Novartis and Moderna. He is currently responsible for leading the validation and standardization activities for Covid-19 vaccine drug substance platform with particular emphasis on Moderna’s Norwood Manufacturing site.

Mr. Allen holds a bachelor’s degree in Chemical Engineering from the University of California at Santa Barbara.